Boundless Bio (BOLD) Accumulated Depreciation (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Accumulated Depreciation of $5.2 million for Q1 2026, up 30.01% year-over-year from $4.0 million in Q1 2025, and up 5.5% quarter-over-quarter from $5.0 million in Q4 2025.
Boundless Bio (BOLD) Accumulated Depreciation (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Accumulated Depreciation for 4 consecutive years, with $5.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Depreciation rose 30.01% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 30.01% YoY), while the FY2025 annual figure was $5.0 million, up 33.73% from the prior year.
- Accumulated Depreciation grew to $5.2 million in Q1 2026 per BOLD's latest filing, from $5.0 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $5.2 million in Q1 2026 and bottomed at $2.7 million in Q4 2023.
- Historically, Accumulated Depreciation has averaged $3.9 million across 4 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2024 — Accumulated Depreciation surged 36.01% — and 2026, when it jumped 30.01%.
- Boundless Bio's Accumulated Depreciation stood at $2.7 million in 2023, then soared by 36.01% to $3.7 million in 2024, then surged by 33.73% to $5.0 million in 2025, then advanced by 5.5% to $5.2 million in 2026.
- Business Quant data shows BOLD's Accumulated Depreciation at $5.2 million in Q1 2026, $5.0 million in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.50 Mn |
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 4.65 Mn |
| Jun 30, 2025 | 4.34 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 3.26 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 2.73 Mn |